. IPF is the first aetiology of chronic idiopathic interstitial pneumonia in adults, and is associated with several comorbidities (4) . Malnutrition, defined as low body mass index (BMI) or low fat-free mass (FFM) (5) (6) (7) (8) , is an independent predictor of mortality in patients with chronic obstructive pulmonary disease (COPD), another chronic, progressive, and irreversible lung disease. FFM is the nutritional indicator the best correlated with COPD patient's survival (7) . Although BMI is widely used to assess nutritional status, it is an insensitive detector of impaired FFM in COPD patients (7, 9) . Bioelectrical impedance analysis (BIA) is the simplest and most accurate method for assessing body composition in clinical practice (9, (11) (12) (13) . Pulmonary rehabilitation improves the FFM of COPD patients (14) . The prognosis for IPF patients with a low BMI (15) or low BMI plus respiratory parameters (16) , and low FFM (17) is poor.
However, to our knowledge, little is known regarding the nutritional assessment of IPF patients. The IPF management guidelines do not cover nutritional status assessment (2, 18) or the nutritional criteria for assessing disease stage and prognosis (2) . Therefore it is needed to determine the best indicators for assessing IPF patients' nutritional status. In this crosssectional study in consecutive IPF patients, we aim to assess the prevalence of malnutrition;
to identify the most reliable clinical and biochemical nutritional indicators (BMI, weight loss, low energy intake, mid-arm circumference, triceps skinfold, serum albumin and transthyretin) for predicting low FFM diagnosed by BIA; and, using multivariate analysis, to identify the demographic, respiratory, and nutritional variables associated with low FFM. Our results should provide practical advice for detecting early stage malnutrition in IPF patients, form the basis for future prospective randomized controlled trials on IPF patient nutrition, and, at best, should contribute to elaborate nutritional recommendations in future IPF guidelines. mA electrical current at frequencies of 5, 50, 100, and 200 kHz produced by the bioimpedance generator/analyser was used to measure whole-body resistance (R) and reactance (Xc) (11) . Phase angles were calculated from: phase angle (°) = arctan(Xc/R) × (180/π). Fat-free mass index (FFMI) was calculated as: fat-free mass (kg) / (height (m) 2 .
FFMI was considered to be low if it was below 17 in men or below 15 in women, as in COPD patients (8, 20) . The body fat mass index (BFMI) was calculated as: fat mass (kg)/(height (m) 2 .
Respiratory and other data collection
Demographic (gender, age) and clinical data (disease duration, comorbidities, current drug use, tobacco use, performance of surgical lung biopsy), pulmonary function test (PFT) and six-minute walk test (6MWT) parameters, were collected from the hospital electronic medical database. Dyspnoea was assessed using the New York Health Association (NYHA) scale.
A C C E P T E D M
A N U S C R I P T 8 PFT and 6MWT were performed according to international guidelines (21, 22) . The gender, age and physiology (GAP) index was calculated as proposed by Ley et al. (23) .
Statistical analysis
Descriptive statistics are expressed as means ± standard deviations (SD) or medians and interquartile ranges for continuous data, according to their distribution, and as the number of patients (with the percentage in parenthesis, followed immediately by the counts for the numerator/denominator) for categorical data. ROC curves were used to analyse the association of each nutritional variable with low FFM and to find the best cut-off associated with low FFM by the Youden method. ROC curves were analysed with their AUCs and 95 % confidence intervals (CIs). The discriminative power of the AUC was defined as: 0.90 ≤ AUC ≤ 1.0, excellent; 0.80 ≤ AUC < 0.90, good; 0.70 ≤ AUC < 0.80, fair; 0.60<AUC< 0.70, poor; 0.50 ≤ AUC < 0.60, failure (24) . We analysed the FFM with χ2 tests (or Fisher's exact test when appropriate) for categorical data, and Student's t-test (or Mann-Whitney-Wilcoxon / Kruskall Wallis test when appropriate) for continuous data. Multivariable logistic regression analysis adjusted for factors with P values of <0.2 in univariate analysis was performed with backward stepwise elimination of all variables that did not contribute (P value ≥0.05). The adjusted Odds ratio of continuous variables was expressed for 1-point increases. Sensitivity, specificity, positive predictive value and negative predictive value, and their 95 % CIs were calculated according to the Youden method. Statistics were computed with SAS software V9.4 (SAS Institute Inc., Cary, NC, USA), and two-tailed P values of <0.05 were considered statistically significant.
RESULTS

Patients' clinical and demographics characteristics
The study included 81 patients (72 (88%) men) with IPF whose clinical characteristics are shown in Table 1 . The mean age was 74.4 ± 8.6 years. Of these, 41 were taking antifibrotic medication at inclusion: 18 (32%) patients with nintedanib (mean duration -597 ± 635 days; range 54 -1765 days) and 23 (28%) with pirfenidone (mean duration -449 ± 267 days; range 20 -1049 days. The remaining 40 patients (49%) were either taking no antifibrotic medication because they were newly diagnosed (n=20 (25%)), did not tolerate or refuse antifibrotic medication, or their disease was too severe to be treated (i.e. FVC < 50% pred and/or TLCO < 30% pred).
Prevalence of malnutrition in IPF patients
In the 81 IPF patients the prevalence of malnutrition based on BIA, i.e. low FFM, was 28% (23/81) ( Table 2 ). This prevalence was lower using other definitions: 4% (3/81) based on BMI<21, 5% (4/81) based on MAC (<250 mm in women and <260 mm in men), and 9% (7/81) based on MMAC (<190 mm in women and <240 mm in men).
Relationship between fat-free mass and clinical and biological nutrition assessment parameters
Low FFMI was significantly associated with lower values for BMI, MAC, TSF, and hence MAMC ( Table 2) . The sensitivity, specificity, positive predictive value, and negative predictive value, defining the capacity of BMI<21 for predicting low FFMI were respectively: 13%, 100%, 100%, and 74%. Lower FFMI was associated with a lower 50 kHz phase angle (25) and a higher percentage of fat mass. Patients with low FFMIs were older, more frequently women, non-smokers, had a lower TLCO, and were less likely to be diagnosed using surgical lung biopsy ( Table 1) . Symptoms (dyspnoea, cough, digital clubbing) or IPF drug therapy were not associated with a low FFMI. Neither were changes in serum albumin FFMI. An IPF patient with a BMI≥25 and a MAC ≥30 cm was 100% likely to have a normal FFMI ( Table 4 ). MAMC (AUC = 0.79, 95% CI, 0.69-0.90) and phase angle (AUC = 0.72, 0.61-0.84) were both fair predictors of FFMI loss.
Relationship between food intake, nutritional parameters, and IPF drug use
As reduced food intake is a well-known indicator of malnutrition, we assessed the factors associated with decreased food intake as indicated by the SEFI®. Patients with an SEFI® analogue score of <7 had a lower TLCO (34.4±13.6%) than those with a SEFI® score ≥7 (46.0±14.9%, P=0.0028), suggesting a link between decreased food intake and disease severity. Patients with a SEFI® analogue score <7 had lower values for MAC (28.3±2.7 vs. 29.9±2.5 cm, P=0.01), MAMC (26.3 ±2.6 vs. 27.6 ±2.3 cm, P=0.025), and phase angle (4.6±1.0 vs. 5.2±0.9 degrees, P=0.012) than those with a SEFI® score ≥7, suggesting a more impaired nutritional status when energy intake is decreased. However, FFMI (17.7 ± 3.3 vs.
18.2 ± 2.3) and the percentage of patients with low FFMI (8/27 (30%) vs. 15/54 (28 %)) were not statistically different in patients with SEFI® score <7 or ≥7. Patients on pirfenidone (6.9 ± A C C E P T E D M A N U S C R I P T 11 2.4) tended to report a lower SEFI® analogue score than patients on nintedanib (7.4 ± 2.7) or who were untreated (8.2 ± 2.3) (P=0.0516).
DISCUSSION
In this cross-sectional study, nearly one third (28%) of the IPF patients were malnourished, as defined by a low FFMI based on BIA. Decreased BMI and MAC, female gender, and neversmoking were strong predictors of low FFM. As a low FFMI has been suggested to affect IPF prognosis (17) , a systematic nutritional assessment should be routinely recommended for IPF patients.
To our knowledge, this is the first study to determine, in IPF patients, if usual nutritional indicators could predict low FFMI measured by BIA. Measuring BMI with a cut-off of <21, as recommended for COPD patients (8, 14, 20) , is an insensitive method for diagnosing malnutrition, and largely underestimates the problem. It indicated that only 4% were malnourished, while a low FFMI derived from BIA diagnoses 28%, indicating that 87% of patients with low FFMI having BMI ≥21 were false negatives. This poor sensitivity of BMI <21 has been reported for COPD patients, for whom BIA is the most sensitive method for diagnosing malnutrition (9, 20) . However, when choosing the right cut-offs, BMI is excellent, and MAC good, at predicting low FFMI. The most discriminative cut-off for BMI was 25.4 with excellent sensitivity and negative predictive value, but the specificity and positive predictive values were poor because it produced many false positives. MAC<295 mm and a combination of BMI and MAC gave similar predictive profiles. We believe that these results will prove useful in daily clinical practice.
Our data indicate that malnutrition is common in IPF patients: nearly one third of them were malnourished. This is important because some studies on IPF patients suggested that a low BMI, alone (15) or combined with respiratory parameters (16) , and low FFM derived from (15) . Patients with a BMI ≥ 30 had a better survival rate than those with BMIs < 25 and 25-30. A retrospective Japanese study on 65 patients with IPF found that a one-point increase in BMI over 12 months was associated with 10% fewer deaths (16) . A recent study of 44 Japanese IPF patients (17) evaluated the prognosis value of FFMI. The FFMI (hazard ratio (HR): 0.64, 95% CI: 0.43-0.94, P=0.02) and percentage predicted FVC (HR: 0.96, 95% CI: 0.93-0.99, P=0.008) were significant predictors of survival. Nutritional status was not correlated with respiratory parameters such as percentage predicted FVC, percentage predicted TLCO, or 6MWT (15, 17) . We found that the percentage predicted TLCO was significantly lower in IPF patients with a low FFMI. It is now clearly needed to determine whether the prognostic prediction could be improved by combining nutritional and respiratory parameters. A low serum albumin was independently associated with increased mortality in 1269 patients with idiopathic interstitial pneumonia on the waiting list for lung transplantation in the US (26) . The clinical profiles of the patients included in these studies differed from those of our patients. In Kishaba et al. study, most of the patients (74%) were treated with prednisone alone or prednisone plus ciclosporin (16) . In Nishiyama et al. study, the patients had lower BMIs, only one had been diagnosed as IPF with a surgical lung biopsy, a lower TLCO, but young patients and those treated with anti-fibrotics ( pirfenidone or nintedanib), or on long-term oxygen therapy were excluded (17) . All those diagnosed with idiopathic interstitial pneumonia before the 2011 guidelines for IPF were published (2) had more severe disease and were eligible to lung transplant (26) . Our cross-sectional study did not assess the relationship between FFMI and prognosis. A longitudinal study is needed to assess the impact of FFMI on survival according to disease severity, and therapy (oxygen supplements or anti-
fibrotic medications), in normal clinical practice. Nevertheless, the link between the loss of FFM and prognosis and illness severity emphasises the value of using BIA for managing patients with chronic diseases like IPF.
As expected, those patients with decreased FFMI were relatively old. The fact that patients diagnosed by surgical lung biopsy were less likely to have a low FFMI could be explained by their early diagnosis as they did not have to wait for there to be honeycombing on the chest CT-scan (27, 28), indicating more severe disease at the time of nutritional screening. We have no clear explanation why women and non-smokers are so likely to lose FFMI. The mechanisms underlying malnutrition in IPF patients remain unclear. As reported in COPD patients (29, 30), anorexia, insulin resistance, inflammation, and hypogonadism could all be involved. However, we found no link between food intake or C-reactive protein (CRP) concentration and FFMI. Nevertheless, the mean CRP concentration in our IPF patients (8.2 ± 12.1 mg/L) was higher than those of COPD patients (3-4 mg/L), who are known to suffer from systemic inflammation (31, 32).
We focussed specifically on antifibrotic therapy, but found no difference in the nutritional status of untreated patients and those treated with pirfenidone or nintedanib. However, patients on pirfenidone reported a slight decrease in food intake; this needs to be confirmed.
BIA was chosen as the reference method for assessing FFM because it is easy to use for measuring body composition at the bedside or in outpatients (11) (12) (13) , and has been well validated as an accurate measure of FFM and prognosis assessment in COPD patients (14) .
Our experience in this study confirmed the ease-of-use of BIA; all the measurements on all patients were obtained by a single physician (SJ) who had never used BIA before.
Finally, this study has some limitations. Weight loss was not taken into account as a nutritional parameter, because many data were missing. They were all based on patients' recall and so could be not considered as precise objective data. A longitudinal study is needed
to assess the predictive value of weight loss for assessing FFMI loss and disease prognosis.
We used the FFMI cut-off values recommended for COPD patients. Nishiyama et al. used the median of FFMI to split their 44 IPF patients (17) . The cut-off was 16.6 kg/m² for both genders, which is quite similar to the COPD cut-offs we used: women <15 and men <17.
However, more studies are needed to determine the optimal cut-off for defining malnutrition in IPF patients.
We conclude that malnutrition (i.e. low FFMI measured by BIA) is highly prevalent (nearly one third) in IPF patients. Therefore, malnutrition screening should become systematic, based on BMI and MAC that are good clinical indicators of low FFMI. Based on these indicators sensitivity, specificity, positive predictive value, and negative predictive value (Figures 1 and   2 , and 
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